Benchmarks settled in the green on Wednesday due to gains in technology and telecom stocks. The S&P 500 and the Dow closed at a record level for the 47th and 30th times this year, respectively. Separately, the Nasdaq was boosted by gains in bio-tech stocks. However, the gains were limited by another slump in energy shares. Meanwhile, the day’s discouraging […]
The past five-plus years have made for some amazing returns for equities investors. Here are some cold hard facts to put the rally into perspective.1. The S&P 500′s Price-to-Sales Ratio Has Never Been HigherMost people have heard of the S&P 500′s price-to-earnings ratio, or perhaps the more accurate Schiller ratio. What many investors aren’t aware of is the lesser-known price-to-sales ratio. […]
Year end is coming up quickly, and that has investors pouring over portfolios, dissecting financial reports, and considering names to own heading into 2015. ;With that in mind, read on to learn why ;I think these three biotech stocks may prove worthy enough of investor wish-lists next month.Source: Cubist Pharmaceuticals1. Treating hospital infectionsOn December 21, the FDA will make a […]
Source: GW PharmaceuticalsMedical marijuana is one of healthcare’s biggest stories this year and shares in marijuana companies are trading near all time highs, but not everyone is convinced that marijuana stocks should be in investor portfolios. So we asked three of our top analysts to weigh in on why they’d take a pass on owning marijuana stocks. Read on to […]
istockphotoThree-year annualized return: 28.1%Annual expense ratio: 0.35%Minimum initial investment: $3,000Biggest holdings: Actavis, Merck, Bristol-Myers Squibb, UnitedHealth Group, AstraZenecaVanguard Health Care (VGHCX) is the Grand Pooh-Bah of health care sector funds. Not only is it the biggest, it also charges the least of any health care mutual fund (exchange-traded funds tend to cost less). What’s more, even as Vanguard Health outpaced […]
Last week, earnings remained in focus with several companies reporting their third quarter results. While AbbVie’s (ABBV – Analyst Report) results remained strong with the company raising its outlook, companies like Regeneron (REGN – Analyst Report) and Aegerion (AEGR – Analyst Report) narrowed their sales outlooks for their key products.Among all this, Geron (GERN – Analyst Report) made it to […]
Big Data has a lot of potential for true personalized one-to-one marketing. Combining different data sets to create a detailed view of your customers is a powerful tool to increase your sales and increase your conversion rates. Combining customer data with social data and mobile data, the ‘Data-triangle‘ as I explained earlier, can provide you with valuable customer insights. Quite […]
Stock Market Negative Expectations Following Short-Term ConsolidationStock-Markets / Stock Markets 2014Aug 28, 2014 – 02:21 PM GMTBy: Paul_RejczakBriefly: In our opinion, speculative short positions are favored (with stop-loss at 2,030, and a profit target at 1,900, S&P 500 index)Our intraday outlook is bearish, and our short-term outlook is bearish:Intraday (next 24 hours) outlook: bearishShort-term (next 1-2 weeks) outlook: bearishMedium-term (next […]
Big data has become the big thing recently and seems to be all anyone is talking about (besides it being the year of mobile, of course). By “big data,” we mean a concentrated effort to gather intelligence about your business so you can accomplish a deeper analysis.The fanfare isn’t unwarranted, though. Big data allows you to get a better understanding […]
Stock Trading Alert: Indexes May Open Higher As Investors’ Sentiment ImprovesBy: Paul Rejczak | Mon, Aug 25, 2014SharePrintEmailStock Trading Alert originally published on August 25, 2014, 7:10 AMBriefly: In our opinion, no speculative positions are justified.Our intraday outlook is neutral, and our short-term outlook is neutral:Intraday (next 24 hours) outlook: neutralShort-term (next 1-2 weeks) outlook: neutralMedium-term (next 1-3 months) outlook: […]
